Literature DB >> 15504405

Folding mechanism of the CH2 antibody domain.

Matthias J Feige1, Stefan Walter, Johannes Buchner.   

Abstract

The immunoglobulin C(H)2 domain is a simple model system suitable for the study of the folding of all-beta-proteins. Its structure consists of two beta-sheets forming a greek-key beta-barrel, which is stabilized by an internal disulfide bridge located in the hydrophobic core. Crystal structures of various antibodies suggest that the C(H)2 domains of the two heavy chains interact with their sugar moieties and form a homodimer. Here, we show that the isolated, unglycosylated C(H)2 domain is a monomeric protein. Equilibrium unfolding was a two-state process, and the conformational stability is remarkably low compared to other antibody domains. Folding kinetics of C(H)2 were found to consist of several phases. The reactions could be mapped to three parallel pathways, two of which are generated by prolyl isomerizations in the unfolded state. The slowest folding reaction, which was observed only after long-term denaturation, could be catalyzed by a prolyl isomerase. The majority of the unfolded molecules, however, folded more rapidly, on a time-scale of minutes. Presumably, these molecules also have to undergo prolyl isomerization before reaching the native state. In addition, we detected a small number of fast-folding molecules in which all proline residues appear to be in the correct conformation. On both prolyl isomerization limited pathways, the formation of partly structured intermediates could be observed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504405     DOI: 10.1016/j.jmb.2004.09.033

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  36 in total

1.  Elucidation of acid-induced unfolding and aggregation of human immunoglobulin IgG1 and IgG2 Fc.

Authors:  Ramil F Latypov; Sabine Hogan; Hollis Lau; Himanshu Gadgil; Dingjiang Liu
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

2.  The impact of glycosylation on monoclonal antibody conformation and stability.

Authors:  Kai Zheng; Christopher Bantog; Robert Bayer
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

3.  Generation and comparative characterization of glycosylated and aglycosylated human IgG1 antibodies.

Authors:  Dmitrij Hristodorov; Rainer Fischer; Hannah Joerissen; Beate Müller-Tiemann; Heiner Apeler; Lars Linden
Journal:  Mol Biotechnol       Date:  2013-03       Impact factor: 2.695

4.  Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeutics.

Authors:  Tianlei Ying; Weizao Chen; Yang Feng; Yanping Wang; Rui Gong; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

5.  Improving biophysical properties of a bispecific antibody scaffold to aid developability: quality by molecular design.

Authors:  Thomas Spreter Von Kreudenstein; Eric Escobar-Carbrera; Paula I Lario; Igor D'Angelo; Karine Brault; John Kelly; Yves Durocher; Jason Baardsnes; R Jeremy Woods; Michael Hongwei Xie; Pierre-Alain Girod; Michael D L Suits; Martin J Boulanger; David K Y Poon; Gordon Y K Ng; Surjit B Dixit
Journal:  MAbs       Date:  2013-07-08       Impact factor: 5.857

Review 6.  Engineered CH2 domains (nanoantibodies).

Authors:  Dimiter S Dimitrov
Journal:  MAbs       Date:  2009 Jan-Feb       Impact factor: 5.857

7.  Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor.

Authors:  Rui Gong; Yanping Wang; Yang Feng; Qi Zhao; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

8.  Expression, purification, and characterization of engineered antibody CH2 and VH domains.

Authors:  Rui Gong; Weizao Chen; Dimiter S Dimitrov
Journal:  Methods Mol Biol       Date:  2012

Review 9.  With or without sugar? (A)glycosylation of therapeutic antibodies.

Authors:  Dmitrij Hristodorov; Rainer Fischer; Lars Linden
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

10.  Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain.

Authors:  Arnold McAuley; Jaby Jacob; Carl G Kolvenbach; Kimberly Westland; Hyo Jin Lee; Stephen R Brych; Douglas Rehder; Gerd R Kleemann; David N Brems; Masazumi Matsumura
Journal:  Protein Sci       Date:  2008-01       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.